This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Samuelson, D. J. Articles by Gould, M. N. Search for Related Content PubMed PubMed Citation Articles by Samuelson, D. J. Articles by Gould, M. N.

Fine Mapping Reveals Multiple Loci and a Possible Epistatic Interaction within the Mammary Carcinoma Susceptibility Quantitative Trait Locus, Mcs5

McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, Wisconsin

Requests for reprints: Michael N. Gould, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, 1400 University Avenue, Madison, WI 53706-1599. Phone: 608-263-6026; Fax: 608-262-2824; E-mail: gould{at}oncology.wisc.edu.

To identify high-frequency, low-penetrance breast cancer modifier genes, we have developed a rat genetic model that uses the Wistar-Kyoto (WKy) inbred strain, resistant to developing 7,12-dimethylbenz[a]anthracene–induced mammary carcinogenesis, as a congenic donor and the susceptible Wistar-Furth (WF) strain as the recipient. Here, data from congenic rat lines containing smaller WKy genomic intervals of the Mcs5 quantitative trait locus region are presented to fine map three independently acting Mcs5 subloci. WKy-homozygous females from congenic lines defining Mcs5a, Mcs5b, and Mcs5c averaged, respectively, 4.0 ± 0.4, 11.6 ± 0.6, and 3.5 ± 0.4 mammary carcinomas per rat. These phenotypic values are statistically different from the WF-homozygous phenotype value of 8.0 ± 0.4, which is the baseline phenotype used for these experiments. We identified a likely Mcs5a x Mcs5b epistatic interaction that results in masking the increased susceptibility effect of the Mcs5b WKy allele by the Mcs5a WKy allele. We also provide evidence for a Mcs5a x Mcs5c interaction that is synergistic to decrease mammary carcinoma susceptibility below the additive effects of WKy alleles at each locus independently. The Mcs5 subloci are currently localized to 1.0, 7.5, and 4.5 Mb of rat chromosome 5, and the orthologous regions are on human chromosome 9 and mouse chromosome 4. These loci will provide unbiased candidate gene loci for evaluation in human case-control association studies.

This article has been cited by other articles:

				M. N. Gould The Utility of Comparative Genetics to Inform Breast Cancer Prevention Strategies Genetics, October 1, 2009; 183(2): 409 - 412. [Abstract] [Full Text] [PDF]

				D. J. Samuelson, S. E. Hesselson, B. A. Aperavich, Y. Zan, J. D. Haag, A. Trentham-Dietz, J. M. Hampton, B. Mau, K.-S. Chen, C. Baynes, et al. Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk PNAS, April 10, 2007; 104(15): 6299 - 6304. [Abstract] [Full Text] [PDF]

				B. S. Schaffer, C. M. Lachel, K. L. Pennington, C. R. Murrin, T. E. Strecker, M. Tochacek, K. A. Gould, J. L. Meza, R. D. McComb, and J. D. Shull Genetic Bases of Estrogen-Induced Tumorigenesis in the Rat: Mapping of Loci Controlling Susceptibility to Mammary Cancer in a Brown Norway x ACI Intercross. Cancer Res., August 1, 2006; 66(15): 7793 - 7800. [Abstract] [Full Text] [PDF]